Proton pump inhibitor and histamine-2 receptor antagonist use and risk of gastric cancer in two population-based studies.

  • Peipei Liu (Advisor)

Activity: Talk or presentation types › Oral presentation

Period18 Oct 2019
Held atUlster Society of Gastroenterology

Related content